MIRA INFORM REPORT

 

 

Report Date :

12.10.2011

 

IDENTIFICATION DETAILS

 

Name :

ALPHAMOUN PHARMACEUTICALS CO SAE

 

 

Registered Office :

Cairo-Ismalia Road, Km-76 First Industrial Zone, El Obour City PO Box  5 Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2010

 

 

Year of Establishment :

1989

 

 

Com. Reg. No.:

1677, El Obour

 

 

Legal Form :

Egyptian Joint Stock Company

 

 

Line of Business :

Production of various chemicals.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 2,000,000

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

(31.12.2010)

Current Rating

(31.03.2011)

Egypt

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

SUMMARY

 

Company Name                         : ALPHAMOUN PHARMACEUTICALS CO SAE

Country of Origin                                    : Egypt

Legal Form                                            : Egyptian Joint Stock Company

Registration Date                                   : 1989

Commercial Registration Number            : 1677, El Obour

Tax Card Number                                   : 324-927-835

Issued Capital                                        : £E 1,360,572,200

Paid up Capital                                      : £E 1,360,572,200

Total Workforce                                     : 2,800

Activities                                               : Production of various chemicals.

Financial Condition                                 : Good

Payments                                             : Nothing detrimental uncovered

Operating Trend                                     : Steady

Recommended Credit Limit                     : US$ 2,000,000

COMPANY NAME

 

ALPHAMOUN PHARMACEUTICALS CO SAE

 

 

ADDRESS

 

Registered & Physical Address

 

Street               : Cairo-Ismalia Road, Km-76

Area                 : First Industrial Zone, El Obour City

 

PO Box             : 5

 

Town                 : Cairo

Country             : Egypt

 

Telephone         : (20-2) 46140000 / 46149133 / 46140100 / 46101333

Facsimile          : (20-2) 46140165 / 46140061 / 46140190

Mobile               : (20-10) 6003000

Email                : hr@amoun.com

 

Premises

 

Subject operates from a large suite of offices and a factory that are owned and located in the Industrial Area of Cairo.

 

Branch Office (s)

 

     Location                                                                                           Description

 

·       El Saydla Building                                                                             Office premises

Smouha

Alexandria

Tel: (20-3) 4268132

 

·       24 Corniche El Nile Street                                                                  Office premises

Assiut

Tel: (20-88) 2313135

 

·       Amin Abou Zeid Street                                                                       Office premises

Heliopolis

Cairo

Tel: (20-2) 46971807

Fax: (20-2) 46972822

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Dr Raed Shoukry Ibrahim                                                                   Chairman

 

·       Ashley John Dunster                                                                         Director

 

·       Mohamed Salah Younes                                                                    Director

 

·       Amardeep Singh                                                                               Director

 

·       Anis Anton Aclimandos                                                                     Director

 

·       Solis Nayer                                                                                       Director

 

·       Hanan Kamal                                                                                    Human Resources Manager

 

·       Michael Guirguis                                                                               Finance Manager

 

·       Dr Gehan Abd El Massih Tadros                                                         Production Manager

 

·       Dr Hany Kamil                                                                                  Quality Manager

 

·       Mariam Wahaba                                                                                Office Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1989

 

Legal Form                  : Egyptian Joint Stock Company

 

Commercial Reg. No.  : 1677, El Obour

 

Tax Card No.               : 324-927-835

 

Authorised Capital       : £E 2,000,000,000

 

Issued Capital              : £E 1,360,572,200

 

Paid up Capital            : £E 1,360,572,200

 

Name of Shareholder (s)                                     Percentage

 

·       Mercury Egypt Pharmaceuticals                                      98.8%

 

·       Egyptian businessmen and private investors                       1.2%

OPERATIONS

 

Activities: Engaged in the production of various chemicals, including amines, raw materials for pharmaceuticals and  parapharmaceutical preparations, as well as aerosol bottles and containers.

 

Import Countries: France, Germany and Belgium

 

Export Countries: The United States of America, Romania, Russia, Kenya, Ethiopia and 14 Arab States

 

Operating Trend: Steady

 

Subject has a workforce of approximately 2,800 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)

 

                                                Year Ending 31/12/09:                Year Ending 31/12/10:

 

Total Sales                                £E 509,036,952                         £E 579,512,623

 

Local sources consider subject’s financial condition to be Good.

 

The above financial figures are based on estimations by our local sources.

 

 

BANKERS

 

·       Banque du Caire SAE

22 Adly Street

PO Box: 1495

Cairo

Tel: (20-2) 33904554

Fax: (20-2) 33908992

 

·       Misr International Bank (MIBANK)

14 Alfy Street

     PO Box: 631

     Cairo

     Tel: (20-2) 35931002

     Fax: (20-2) 35912306

 

·       National Bank of Egypt

24 Sherif Street

     Cairo

     Tel: (20-2) 33924175

     Fax: (20-2) 33924143

 

·       Banque Misr

151 Mohamed Farid Street

Cairo

Tel: (20-2) 33912711 / 33912106

Fax: (20-2) 33919779

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Local sources report that payment obligations are met in a generally timely manner and the operating history is clear. As such the company is deemed a fair trade risk and the above credit figure is considered to be within subject’s financial means.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.49.03

UK Pound

1

Rs.76.60

Euro

1

Rs.66.80

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.